Lovastatin induces VSMC differentiation through inhibition of Rheb and mTOR. [electronic resource]
- American journal of physiology. Cell physiology Jul 2010
- C119-27 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1522-1563
10.1152/ajpcell.00429.2009 doi
Angioplasty, Balloon Animals Cardiovascular Agents--pharmacology Cell Differentiation--drug effects Cells, Cultured Contractile Proteins--metabolism Dose-Response Relationship, Drug Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology Intracellular Signaling Peptides and Proteins--antagonists & inhibitors Lovastatin--pharmacology Mechanistic Target of Rapamycin Complex 1 Monomeric GTP-Binding Proteins--antagonists & inhibitors Multiprotein Complexes Muscle, Smooth, Vascular--drug effects Myocytes, Smooth Muscle--drug effects Neuropeptides--antagonists & inhibitors Phosphorylation Protein Kinase Inhibitors--pharmacology Protein Prenylation Protein Serine-Threonine Kinases--antagonists & inhibitors Proteins RNA Interference Ras Homolog Enriched in Brain Protein Signal Transduction--drug effects Swine TOR Serine-Threonine Kinases Time Factors Tissue Culture Techniques Transcription Factors--metabolism Transfection